Dermatology NewsSpecific markers detect psoriatic disease inflammation without elevated CRPFebruary 25, 2020Psoriatic ArthritisPsoriasis
Dermatology NewsPsoriasis elevates cancer riskFebruary 20, 2020PsoriasisPsoriatic ArthritisNonmelanoma Skin Cancer
Dermatology NewsNonspecific musculoskeletal symptoms might indicate early PsAFebruary 10, 2020Psoriatic ArthritisPsoriasis
Dermatology NewsTildrakizumab signals safe for pregnant psoriasis patientsFebruary 7, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsPsoriasis: A look back over the past 50 years, and forward to next stepsJanuary 29, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsRegistry data reveal temporal relationship between psoriasis symptoms and PsA onsetJanuary 29, 2020Psoriatic ArthritisPsoriasis
Dermatology NewsApremilast more likely to succeed with moderate psoriatic arthritis activityJanuary 22, 2020Psoriatic Arthritis
Dermatology NewsMeta-analysis provides safety data on IL-17, IL-23 inhibitorsJanuary 2, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsUltrasound improves specificity of psoriatic arthritis referralsDecember 19, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsEvidence builds for effects of obesity, low physical activity on development of psoriatic arthritisDecember 12, 2019Psoriatic Arthritis
Dermatology NewsRepeat LTBI testing best in patients taking biologics with new risk factorsDecember 9, 2019Psoriatic ArthritisInfectious DiseasesPsoriasis
Dermatology NewsFDA approves infliximab-axxq for numerous indicationsDecember 6, 2019Psoriatic ArthritisPsoriasis
Dermatology NewsCertolizumab safety profile varies widely across indicationsNovember 27, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsSPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsANovember 21, 2019Psoriatic ArthritisPsoriasis
